Clinical response of recurrence risk and the SGLT2 inhibitor of the ischemic heart disease
Latest Information Update: 15 Jul 2016
At a glance
- Drugs Empagliflozin (Primary)
- Indications Ischaemic heart disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Jul 2016 New trial record